Procter & Gamble reported that its core organic sales growth, while modest at 1.5% year-over-year in the latest quarter, exceeded consensus expectations for flat performance. Management emphasized that the business has navigated input cost pressures and foreign exchange headwinds, and now sees the trough of the cycle behind it. Free cash flow for the trailing twelve months stood at $14.2 billion, supporting balance sheet health and enabling continued investment in brand innovation across Beauty, Fabric & Home Care and Health Care segments.

In its most recent 13F filing, GDS Wealth Management disclosed the acquisition of an additional 14,060 shares of Procter & Gamble during the third quarter, raising its total stake to 81,190 shares valued at approximately $12.5 million at quarter end. This move underscores institutional confidence in P&G’s ability to sustain dividend growth, with a current yield near 2.8% and a payout ratio around 63%.

While GDS Wealth added to its position, Cullen Frost Bankers trimmed its holding by 13.1%, selling 40,550 shares and ending the period with 269,251 shares (worth roughly $41.4 million). Commerzbank Aktiengesellschaft reduced its stake by 8.0% to 574,956 shares, and Baillie Gifford pared back by 2.8% to 919,290 shares. Conversely, BAM Wealth Management initiated a new $0.7 million position and Acorn Wealth Advisors expanded by 4.5% to over 4,000 shares. Institutional ownership remains high at 65.8%, reflecting diverse strategies around P&G’s defensive, dividend-oriented profile.

In the quarter ended January 22, Procter & Gamble delivered adjusted earnings per share of $1.88, beating analyst estimates by $0.02, while revenues of $22.21 billion rose 1.5% year-over-year. Return on equity held strong at 32.1%, and net margin settled at 19.3%. The company reaffirmed full-year guidance of $6.83 to $7.09 EPS, and declared a quarterly dividend of $1.0568 per share, payable February 17, marking the 66th consecutive year of dividend increases.